The BioNTech/Pfizer jab was the first vaccine against COVID-19 to be approved late last year. Germany’s BioNTech and its US partner Pfizer on Friday said tests have shown that their coronavirus vaccine can stand warmer temperatures than initially thought, potentially simplifying the jab’s complex cold-chain logistics. The companies said they have asked the US Food … Read more
Experts advising the US Food and Drug Administration (FDA) have recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine. The decision is coming on the heel of a 23-member panel meeting to determine whether the drug’s benefits outweigh the risks. BBC reports that the Pfizer vaccine has already been approved for the public in the UK, … Read more
British public health officials, on Wednesday, warned that people with a history of significant allergic reactions should not have the Pfizer-BioNTech vaccine for now. AFP reports that this is coming after two members of the National Health Service who were among the first to receive the vaccine on Tuesday suffered allergic reactions and needed treatment. … Read more
NOVEMBER 18, 2020 Pfizer and BioNTech, on Wednesday, said that a completed study of their experimental Covid-19 vaccine showed it was 95 percent effective. They said the two-dose vaccine had no serious safety concerns and that the companies will apply for emergency use authorization from US regulators “within days.” AFP reports that the announcement came … Read more
NOVEMBER 13, 2020 The Director-General of the World Health Organization hailed the rapid progress towards a Covid-19 vaccine but has insisted that every country must reap the benefits. “A vaccine will be a vital tool for controlling the pandemic, and we’re encouraged by the preliminary results of clinical trials released this week,” Tedros Adhanom Ghebreyesus … Read more